Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Visual Impairment Due to Diabetic Macular Edema”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Post-approval studies (Phase 4)WithdrawnNCT02258009
What this trial is testing

Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Visual Impairment Due to Diabetic Macular Edema
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00687804
What this trial is testing

A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study

Who this might be right for
Diabetic Macular Edema
Novartis 345
Not applicableStudy completedNCT02850263
What this trial is testing

Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema

Who this might be right for
Macular Edema
Bayer 750
Post-approval studies (Phase 4)Study completedNCT01297569
What this trial is testing

Ranibizumab "Treat and Extend" in Diabetic Macular Edma

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 7
Large-scale testing (Phase 3)Study completedNCT02262260
What this trial is testing

Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 87
Post-approval studies (Phase 4)Study completedNCT01315275
What this trial is testing

A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema

Who this might be right for
Visual ImpairmentMacular Edema
Novartis Pharmaceuticals 394
Testing effectiveness (Phase 2)Study completedNCT02732951
What this trial is testing

Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema

Who this might be right for
Macular Edema
Boehringer Ingelheim 105
Not applicableActive Not RecruitingNCT06075147
What this trial is testing

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

Who this might be right for
Visual ImpairmentNeovascular Age-related Macular Degeneration (nAMD)Diabetic Macula Edema (DME)
Bayer 2,500
Large-scale testing (Phase 3)Study completedNCT03481660
What this trial is testing

The Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 360
Not applicableStudy completedNCT03889444
What this trial is testing

Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Allergan 141
Large-scale testing (Phase 3)Study completedNCT01135914
What this trial is testing

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 241
Large-scale testing (Phase 3)Study completedNCT01331681
What this trial is testing

Intravitreal Aflibercept Injection in Vision Impairment Due to DME

Who this might be right for
Diabetes MellitusMacular Edema
Bayer 406
Large-scale testing (Phase 3)Study completedNCT00989989
What this trial is testing

Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Novartis 396
Large-scale testing (Phase 3)Ended earlyNCT02032173
What this trial is testing

Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase

Who this might be right for
Macular EdemaMacular DegenerationDiabetes
Novartis Pharmaceuticals 31
Large-scale testing (Phase 3)Study completedNCT04058067
What this trial is testing

To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 266
Large-scale testing (Phase 3)Ended earlyNCT01131585
What this trial is testing

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema

Who this might be right for
Visual Impairment Due to Diabetic Macular Edema
Novartis Pharmaceuticals 128
Large-scale testing (Phase 3)Study completedNCT02259088
What this trial is testing

A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients

Who this might be right for
Diabetic Macular EdemaVisual Impairment
Novartis Pharmaceuticals 384
Post-approval studies (Phase 4)WithdrawnNCT02878681
What this trial is testing

24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.

Who this might be right for
Visual Impairment Due to Diabetic Macular Edema
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT05112861
What this trial is testing

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 120
Not applicableStudy completedNCT04543331
What this trial is testing

Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Diabetic Macular Edema (DME)
Novartis Pharmaceuticals 572
Load More Results